Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Agios Pharmaceuticals, Inc. (AGIO) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Agios Pharmaceuticals, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1439222.
Total stock buying since 2015: $225,626,257.
Total stock sales since 2015: $157,286,004.
Total stock option exercises since 2015: $24,780,238.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 90,509 | $3,121,937 | 214,923 | $326,913 |
| 2024 | 0 | $0 | 275,285 | $9,802,098 | 387,362 | $4,872,997 |
| 2023 | 0 | $0 | 194,302 | $5,025,995 | 310,521 | $1,505,335 |
| 2022 | 0 | $0 | 845 | $26,168 | 119,506 | $0 |
| 2021 | 0 | $0 | 106,656 | $6,265,395 | 156,788 | $4,142,759 |
| 2020 | 0 | $0 | 64,436 | $3,229,621 | 143,981 | $1,943,537 |
| 2019 | 451,611 | $13,999,941 | 47,950 | $3,126,690 | 121,498 | $1,467,533 |
| 2018 | 851,354 | $57,044,006 | 432,950 | $35,552,561 | 515,767 | $5,601,645 |
| 2017 | 3,122,875 | $154,582,310 | 681,522 | $38,011,569 | 269,401 | $598,898 |
| 2016 | 0 | $0 | 97,536 | $5,752,222 | 194,199 | $1,852,082 |
| 2015 | 0 | $0 | 492,204 | $47,371,748 | 323,656 | $2,468,539 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-02-27 | Schenkein David P | Option Ex | 20,000 | 9.05 | 181,000 |
| 2023-02-16 | Washburn Theodore James Jr. (Principal Accounting Officer) | Sale | 233 | 27.21 | 6,339 |
| 2023-02-14 | Burns James William (Chief Legal Officer) | Option Ex | 1,738 | .00 | 0 |
| 2023-02-14 | Washburn Theodore James Jr. (Principal Accounting Officer) | Sale | 504 | 28.59 | 14,409 |
| 2023-02-14 | Washburn Theodore James Jr. (Principal Accounting Officer) | Option Ex | 360 | .00 | 0 |
| 2023-02-14 | Fouse Jacqualyn A | Option Ex | 11,333 | .00 | 0 |
| 2023-02-13 | Schenkein David P | Sale | 20,000 | 28.62 | 572,400 |
| 2023-02-13 | Schenkein David P | Option Ex | 20,000 | 9.05 | 181,000 |
| 2023-02-10 | Washburn Theodore James Jr. (Principal Accounting Officer) | Option Ex | 777 | .00 | 0 |
| 2023-01-30 | Schenkein David P | Sale | 20,000 | 29.55 | 591,000 |
| 2023-01-30 | Schenkein David P | Option Ex | 20,000 | 9.05 | 181,000 |
| 2022-12-23 | Burns James William (Chief Legal Officer) | Option Ex | 8,750 | .00 | 0 |
| 2022-12-23 | Gheuens Sarah (Chief Medical Officer) | Option Ex | 9,375 | .00 | 0 |
| 2022-10-15 | Poddar Richa (Chief Commercial Officer) | Option Ex | 10,000 | .00 | 0 |
| 2022-05-20 | Scadden David | Option Ex | 1,585 | .00 | 0 |
| 2022-05-20 | Ho Maykin | Option Ex | 1,585 | .00 | 0 |
| 2022-05-20 | Schenkein David P | Option Ex | 1,585 | .00 | 0 |
| 2022-05-20 | Clancy Paul J | Option Ex | 1,585 | .00 | 0 |
| 2022-05-20 | Clark Ian T | Option Ex | 1,585 | .00 | 0 |
| 2022-05-20 | Foster-cheek Kaye I | Option Ex | 1,585 | .00 | 0 |
| 2022-05-20 | Maraganore John | Option Ex | 1,585 | .00 | 0 |
| 2022-02-25 | Washburn Theodore James Jr. (Principal Accounting Officer) | Sale | 108 | 30.00 | 3,240 |
| 2022-02-22 | Burns James William (Chief Legal Officer) | Option Ex | 724 | .00 | 0 |
| 2022-02-22 | Poddar Richa (Chief Commercial Officer) | Option Ex | 658 | .00 | 0 |
| 2022-02-22 | Washburn Theodore James Jr. (Principal Accounting Officer) | Option Ex | 167 | .00 | 0 |
| 2022-02-22 | Schenkein David P | Option Ex | 2,775 | .00 | 0 |
| 2022-02-18 | Poddar Richa (Chief Commercial Officer) | Option Ex | 1,884 | .00 | 0 |
| 2022-02-18 | Gheuens Sarah (Chief Medical Officer) | Option Ex | 3,271 | .00 | 0 |
| 2022-02-18 | Car Bruce (Chief Scientific Officer) | Option Ex | 6,874 | .00 | 0 |
| 2022-02-18 | Biller Jonathan (Chief Financial Officer) | Option Ex | 8,523 | .00 | 0 |
| 2022-02-18 | Fouse Jacqualyn A (Chief Executive Officer) | Option Ex | 12,379 | .00 | 0 |
| 2022-02-16 | Washburn Theodore James Jr. (Principal Accounting Officer) | Sale | 233 | 30.81 | 7,178 |
| 2022-02-14 | Burns James William (Chief Legal Officer) | Option Ex | 6,988 | .00 | 0 |
| 2022-02-14 | Poddar Richa (Chief Commercial Officer) | Option Ex | 1,738 | .00 | 0 |
| 2022-02-14 | Washburn Theodore James Jr. (Principal Accounting Officer) | Sale | 504 | 31.25 | 15,750 |
| 2022-02-14 | Washburn Theodore James Jr. (Principal Accounting Officer) | Option Ex | 360 | .00 | 0 |
| 2022-02-14 | Fouse Jacqualyn A (Chief Executive Officer) | Option Ex | 11,334 | .00 | 0 |
| 2022-02-10 | Burns James William (Chief Legal Officer) | Option Ex | 1,833 | .00 | 0 |
| 2022-02-10 | Poddar Richa (Chief Commercial Officer) | Option Ex | 2,068 | .00 | 0 |
| 2022-02-10 | Gheuens Sarah (Chief Medical Officer) | Option Ex | 2,162 | .00 | 0 |
| 2022-02-10 | Washburn Theodore James Jr. (Principal Accounting Officer) | Option Ex | 777 | .00 | 0 |
| 2022-02-10 | Car Bruce (Chief Scientific Officer) | Option Ex | 3,667 | .00 | 0 |
| 2022-02-10 | Biller Jonathan (Chief Financial Officer) | Option Ex | 3,667 | .00 | 0 |
| 2022-01-06 | Car Bruce (Chief Scientific Officer) | Option Ex | 3,437 | .00 | 0 |
| 2021-12-03 | Biller Jonathan (Chief Financial Officer) | Option Ex | 5,753 | .00 | 0 |
| 2021-12-02 | Gheuens Sarah (Chief Medical Officer) | Option Ex | 834 | .00 | 0 |
| 2021-06-21 | Alenson Carman (Principal Accounting Officer) | Sale | 1,777 | 61.61 | 109,480 |
| 2021-06-21 | Alenson Carman (Principal Accounting Officer) | Option Ex | 1,777 | 51.51 | 91,533 |
| 2021-06-18 | Bowden Christopher (Chief Medical Officer) | Sale | 48,493 | 60.11 | 2,914,865 |
| 2021-06-18 | Bowden Christopher (Chief Medical Officer) | Option Ex | 48,493 | 45.08 | 2,186,064 |
| 2021-06-17 | Bowden Christopher (Chief Medical Officer) | Sale | 2,502 | 60.02 | 150,170 |
| 2021-06-17 | Bowden Christopher (Chief Medical Officer) | Option Ex | 2,502 | 39.76 | 99,479 |
| 2021-06-10 | Bowden Christopher (Chief Medical Officer) | Sale | 20,853 | 60.06 | 1,252,431 |
| 2021-06-10 | Bowden Christopher (Chief Medical Officer) | Option Ex | 20,853 | 39.76 | 829,115 |
| 2021-06-09 | Bowden Christopher (Chief Medical Officer) | Sale | 7,149 | 60.16 | 430,119 |
| 2021-06-09 | Bowden Christopher (Chief Medical Officer) | Option Ex | 7,149 | 39.76 | 284,244 |
| 2021-05-28 | Ho Maykin | Option Ex | 1,686 | .00 | 0 |
| 2021-05-28 | Schenkein David P | Option Ex | 1,686 | .00 | 0 |
| 2021-05-28 | Clancy Paul J | Option Ex | 1,686 | .00 | 0 |
| 2021-05-14 | Miles Darrin (Chief Commercial Officer) | Sale | 3,462 | 55.41 | 191,829 |
| 2021-04-20 | Bowden Christopher (Chief Medical Officer) | Sale | 14,401 | 55.11 | 793,581 |
| 2021-04-20 | Bowden Christopher (Chief Medical Officer) | Option Ex | 14,401 | 37.46 | 539,461 |
| 2021-04-19 | Bowden Christopher (Chief Medical Officer) | Sale | 3,210 | 55.16 | 177,053 |
| 2021-04-19 | Bowden Christopher (Chief Medical Officer) | Option Ex | 3,210 | 35.16 | 112,863 |
| 2021-04-16 | Alenson Carman (Principal Accounting Officer) | Sale | 1,118 | 55.89 | 62,485 |
| 2021-04-15 | Alenson Carman (Principal Accounting Officer) | Sale | 991 | 54.00 | 53,514 |
| 2021-03-05 | Miles Darrin (Chief Commercial Officer) | Sale | 500 | 48.58 | 24,290 |
| 2021-03-01 | Miles Darrin (Chief Commercial Officer) | Sale | 2,200 | 47.99 | 105,578 |
| 2021-02-22 | Miles Darrin (Chief Commercial Officer) | Option Ex | 725 | .00 | 0 |
| 2021-02-22 | Alenson Carman (Principal Accounting Officer) | Option Ex | 692 | .00 | 0 |
| 2021-02-22 | Bowden Christopher (Chief Medical Officer) | Option Ex | 3,334 | .00 | 0 |
| 2021-02-22 | Schenkein David P | Option Ex | 2,774 | .00 | 0 |
| 2021-02-16 | Miles Darrin (Chief Commercial Officer) | Option Ex | 922 | .00 | 0 |
| 2021-02-16 | Bowden Christopher (Chief Medical Officer) | Option Ex | 2,750 | .00 | 0 |
| 2021-02-16 | Schenkein David P | Option Ex | 8,125 | .00 | 0 |
| 2021-02-14 | Miles Darrin (Chief Commercial Officer) | Option Ex | 8,666 | .00 | 0 |
| 2021-02-14 | Bowden Christopher (Chief Medical Officer) | Option Ex | 4,000 | .00 | 0 |
| 2021-02-14 | Fouse Jacqualyn A (Chief Executive Officer) | Option Ex | 11,333 | .00 | 0 |
| 2021-01-06 | Car Bruce (Chief Scientific Officer) | Option Ex | 3,437 | .00 | 0 |
| 2020-12-03 | Biller Jonathan (Chief Financial Officer) | Option Ex | 5,753 | .00 | 0 |
| 2020-09-02 | Alenson Carman (Principal Accounting Officer) | Sale | 250 | 39.93 | 9,982 |
| 2020-05-29 | Scadden David | Option Ex | 1,878 | .00 | 0 |
| 2020-05-29 | Ho Maykin | Option Ex | 1,878 | .00 | 0 |
| 2020-05-29 | Clancy Paul J | Option Ex | 1,878 | .00 | 0 |
| 2020-05-29 | Clark Ian T | Option Ex | 1,878 | .00 | 0 |
| 2020-05-29 | Foster-cheek Kaye I | Option Ex | 1,878 | .00 | 0 |
| 2020-05-29 | Maraganore John | Option Ex | 1,878 | .00 | 0 |
| 2020-05-20 | Bowden Christopher (Chief Medical Officer) | Sale | 3,583 | 50.01 | 179,200 |
| 2020-05-20 | Bowden Christopher (Chief Medical Officer) | Option Ex | 3,583 | 35.16 | 125,978 |
| 2020-04-22 | Hirsch Andrew (Chief Financial Officer) | Option Ex | 5,893 | .00 | 0 |
| 2020-04-13 | Car Bruce (Chief Scientific Officer) | Option Ex | 6,874 | .00 | 0 |
| 2020-04-13 | Biller Jonathan (Chief Legal Officer) | Option Ex | 8,523 | .00 | 0 |
| 2020-04-13 | Bowden Christopher (Chief Medical Officer) | Option Ex | 5,280 | .00 | 0 |
| 2020-04-13 | Hirsch Andrew (Chief Financial Officer) | Option Ex | 5,387 | .00 | 0 |
| 2020-04-13 | Fouse Jacqualyn A (Chief Executive Officer) | Option Ex | 12,379 | .00 | 0 |
| 2020-03-02 | Alenson Carman (Principal Accounting Officer) | Sale | 345 | 47.30 | 16,318 |
| 2020-02-26 | Alenson Carman (Principal Accounting Officer) | Sale | 472 | 47.12 | 22,240 |
| 2020-02-22 | Alenson Carman (Principal Accounting Officer) | Option Ex | 691 | .00 | 0 |
| 2020-02-22 | Bowden Christopher (Chief Medical Officer) | Option Ex | 3,333 | .00 | 0 |
| 2020-02-22 | Hirsch Andrew (Chief Financial Officer) | Option Ex | 3,333 | .00 | 0 |
| 2020-02-22 | Schenkein David P | Option Ex | 2,775 | .00 | 0 |
| 2020-02-20 | Alenson Carman (Principal Accounting Officer) | Sale | 2,427 | 53.37 | 129,528 |
| 2020-02-16 | Alenson Carman (Principal Accounting Officer) | Option Ex | 3,590 | .00 | 0 |
| 2020-02-16 | Bowden Christopher (Chief Medical Officer) | Option Ex | 2,750 | .00 | 0 |
| 2020-02-16 | Hirsch Andrew (Chief Financial Officer) | Option Ex | 2,750 | .00 | 0 |
| 2020-02-16 | Schenkein David P | Option Ex | 8,125 | .00 | 0 |
| 2020-02-13 | Bowden Christopher (Chief Medical Officer) | Sale | 7,100 | 50.16 | 356,114 |
| 2020-02-13 | Bowden Christopher (Chief Medical Officer) | Option Ex | 7,100 | 35.16 | 249,635 |
| 2020-02-11 | Bowden Christopher (Chief Medical Officer) | Sale | 621 | 50.02 | 31,063 |
| 2020-02-11 | Bowden Christopher (Chief Medical Officer) | Option Ex | 621 | 35.16 | 21,834 |
| 2020-02-05 | Bowden Christopher (Chief Medical Officer) | Option Ex | 35,447 | 35.16 | 1,246,316 |
| 2020-02-04 | Bowden Christopher (Chief Medical Officer) | Sale | 49,638 | 50.07 | 2,485,176 |
| 2020-02-04 | Bowden Christopher (Chief Medical Officer) | Option Ex | 8,526 | 35.16 | 299,774 |
| 2019-12-26 | Alenson Carman (Principal Accounting Officer) | Sale | 2,950 | 50.09 | 147,765 |
| 2019-11-13 | Schenkein David P | Buy | 8,064 | 31.00 | 249,984 |
| 2019-11-13 | Fouse Jacqualyn A (Chief Executive Officer) | Buy | 40,322 | 31.00 | 1,249,982 |
| 2019-11-12 | Celgene Alpine Investment Co., Llc | Buy | 403,225 | 31.00 | 12,499,975 |
| 2019-06-11 | Biller Scott (Chief Scientific Officer) | Option Ex | 7,218 | 2.34 | 16,875 |
| 2019-05-31 | Scadden David (Director) | Option Ex | 1,400 | .00 | 0 |
| 2019-05-31 | Ho Maykin (Director) | Option Ex | 1,400 | .00 | 0 |
| 2019-05-31 | Clancy Paul J (Director) | Option Ex | 1,400 | .00 | 0 |
| 2019-05-31 | Fouse Jacqualyn A (Chief Executive Officer) | Option Ex | 1,400 | .00 | 0 |
| 2019-05-31 | Clark Ian T (Director) | Option Ex | 1,400 | .00 | 0 |
| 2019-05-31 | Foster-cheek Kaye I (Director) | Option Ex | 1,400 | .00 | 0 |
| 2019-05-31 | Maraganore John (Director) | Option Ex | 1,400 | .00 | 0 |
| 2019-04-05 | Biller Scott (Chief Scientific Officer) | Sale | 3,000 | 67.86 | 203,594 |
| 2019-04-05 | Biller Scott (Chief Scientific Officer) | Option Ex | 3,000 | 39.76 | 119,280 |
| 2019-04-01 | Bowden Christopher (Chief Medical Officer) | Sale | 10,000 | 67.42 | 674,230 |
| 2019-04-01 | Bowden Christopher (Chief Medical Officer) | Option Ex | 10,000 | 35.16 | 351,599 |
| 2019-03-15 | Bowden Christopher (Chief Medical Officer) | Sale | 10,000 | 64.36 | 643,650 |
| 2019-03-15 | Bowden Christopher (Chief Medical Officer) | Option Ex | 10,000 | 35.16 | 351,599 |
| 2019-03-05 | Biller Scott (Chief Scientific Officer) | Sale | 3,000 | 67.47 | 202,401 |
| 2019-03-05 | Biller Scott (Chief Scientific Officer) | Option Ex | 3,000 | 35.70 | 107,100 |
| 2019-03-04 | Hoerter Steven L. (Chief Commercial Officer) | Sale | 5,000 | 68.00 | 340,000 |
| 2019-03-04 | Hoerter Steven L. (Chief Commercial Officer) | Option Ex | 5,000 | 39.76 | 198,800 |
| 2019-03-01 | Hoerter Steven L. (Chief Commercial Officer) | Sale | 5,000 | 66.01 | 330,050 |
| 2019-03-01 | Hoerter Steven L. (Chief Commercial Officer) | Option Ex | 5,000 | 39.76 | 198,800 |
| 2019-02-27 | Biller Scott (Chief Scientific Officer) | Sale | 9,000 | 65.00 | 585,000 |
| 2019-02-27 | Biller Scott (Chief Scientific Officer) | Option Ex | 9,000 | 13.72 | 123,480 |
| 2019-02-21 | Alenson Carman (Principal Accounting Officer) | Option Ex | 3,300 | .00 | 0 |
| 2019-02-16 | Alenson Carman (Principal Accounting Officer) | Option Ex | 790 | .00 | 0 |
| 2019-02-16 | Bowden Christopher (Chief Medical Officer) | Option Ex | 2,750 | .00 | 0 |
| 2019-02-16 | Hirsch Andrew (Chief Financial Officer) | Option Ex | 2,750 | .00 | 0 |
| 2019-02-16 | Biller Scott (Chief Scientific Officer) | Option Ex | 2,750 | .00 | 0 |
| 2019-02-16 | Schenkein David P (Director) | Option Ex | 8,125 | .00 | 0 |
| 2019-02-16 | Hoerter Steven L. (Chief Commercial Officer) | Option Ex | 2,750 | .00 | 0 |
| 2019-01-20 | Bowden Christopher (Chief Medical Officer) | Option Ex | 6,265 | .00 | 0 |
| 2019-01-20 | Hirsch Andrew (Chief Financial Officer) | Option Ex | 15,000 | .00 | 0 |
| 2019-01-20 | Hoerter Steven L. (Chief Commercial Officer) | Option Ex | 15,000 | .00 | 0 |
| 2018-12-21 | Biller Scott (Chief Scientific Officer) | Option Ex | 20,500 | 2.34 | 47,929 |
Insider trading activities including stock purchases, stock sales, and option exercises of AGIO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Agios Pharmaceuticals, Inc. (symbol AGIO, CIK number 1439222) see the Securities and Exchange Commission (SEC) website.